Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: A randomised, double-blind, placebo-controlled pilot study using MRI

Annals of the Rheumatic Diseases

Volumn 70, Issue 6, 2011, Pages 982-989

  Wildi, Lukas Martin ^a   Raynauld, Jean Pierre ^a   Martel Pelletier, Johanne ^a   Beaulieu, André ^b   Bessette, Louis ^c   Morin, Frédéric ^d   Abram, François ^e   Dorais, Marc ^f   Pelletier, Jean Pierre ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Groupe de Recherche en Rhumatologie et Maladies Osseuses   (Canada)

^d Centre de Recherche Musculo squelettique   (Canada)

^e INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^f StatSciences Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; CONDROSAN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW DISEASE; CARTILAGE DEGENERATION; CHOLECYSTITIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INTOXICATION; EARLY INTERVENTION; EYE DISEASE; FEMALE; FEMUR CONDYLE; GASTROINTESTINAL DISEASE; HEART ATRIUM FIBRILLATION; HUMAN; INFECTION; KIDNEY DISEASE; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLIC DISORDER; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DISORDER; OPEN STUDY; PERIPHERAL EDEMA; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SKIN DISEASE; SYMPTOMATOLOGY; SYNCOPE; SYNOVITIS; SYNOVIUM; TIBIA; TREATMENT DURATION; URINARY DYSFUNCTION; VASCULAR DISEASE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE MARROW DISEASES; CARTILAGE, ARTICULAR; CHONDROITIN SULFATES; DRUG THERAPY, COMBINATION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PATIENT SELECTION; SYNOVIAL MEMBRANE; SYNOVITIS; TREATMENT OUTCOME;

EID: 79955794264     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.140848     Document Type: Article

References (63)

1. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998 ; 41 : 778-99. (Pubitemid 28225778) (Pubitemid 28225778)
2. Felson DT. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am 2004 ; 42 : 1-9. (Pubitemid 38283553) (Pubitemid 38283553)
3. Issa SN, Sharma L. Epidemiology of osteoarthritis: an update. Curr Rheumatol Rep 2006 ; 8 : 7-15. (Pubitemid 44659354) (Pubitemid 44659354)
4. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil 2008 ; 16 : 137-62. (Pubitemid 351222155) (Pubitemid 351222155)
5. Uebelhart D, Thonar EJ, Delmas PD, et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthr Cartil 1998 ; 6 (Suppl A): 39-46. (Pubitemid 28255104) (Pubitemid 28255104)
6. Uebelhart D, Malaise M, Marcolongo R, et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthr Cartil 2004 ; 12 : 269-76. (Pubitemid 38461289) (Pubitemid 38461289)
7. Michel BA, Stucki G, Frey D, et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum 2005 ; 52 : 779-86. (Pubitemid 40365099) (Pubitemid 40365099)
8. Kahan A, Uebelhart D, De Vathaire F, et al. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2009 ; 60 : 524-33.
9. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001 ; 357 : 251-6. (Pubitemid 32120855) (Pubitemid 32120855)
10. Pavelká K, Gatterová J, Olejarová M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, doubleblind study. Arch Intern Med 2002 ; 162 : 2113-23. (Pubitemid 35168220) (Pubitemid 35168220)
11. Bruyere O, Pavelka K, Rovati LC, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthr Cartil 2008 ; 16 : 254-60. (Pubitemid 351218188) (Pubitemid 351218188)
12. Dougados M, Nguyen M, Berdah L, et al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum 2001 ; 44 : 2539-47. (Pubitemid 33049332) (Pubitemid 33049332)
13. Brandt KD, Mazzuca SA, Katz BP, et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum 2005 ; 52 : 2015-25. (Pubitemid 40994324) (Pubitemid 40994324)
14. Raynauld JP, Martel-Pelletier J, Bias P, et al. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis 2009 ; 68 : 938-47.
15. Raynauld JP, Kauffmann C, Beaudoin G, et al. Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees. Osteoarthr Cartil 2003 ; 11 : 351-60. (Pubitemid 36621845) (Pubitemid 36621845)
16. Peterfy CG, Guermazi A, Zaim S, et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthr Cartil 2004 ; 12 : 177-90. (Pubitemid 38248067) (Pubitemid 38248067)
17. Berthiaume MJ, Raynauld JP, Martel-Pelletier J, et al. Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis 2005 ; 64 : 556-63. (Pubitemid 40469084) (Pubitemid 40469084)
18. Loeuille D, Chary-Valckenaere I, Champigneulle J, et al. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. Arthritis Rheum 2005 ; 52 : 3492-501. (Pubitemid 41612215) (Pubitemid 41612215)
19. Conaghan PG, Felson D, Gold G, et al. MRI and non-cartilaginous structures in knee osteoarthritis. Osteoarthr Cartil 2006 ; 14 (Suppl A): A87-94.
20. Hunter DJ, Lo GH, Gale D, et al. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score). Ann Rheum Dis 2008 ; 67 : 206-11. (Pubitemid 351183309) (Pubitemid 351183309)
21. Pelletier JP, Raynauld JP, Abram F, et al. A new non-invasive method to assess synovitis severity in relation to symptoms and cartilage volume loss in knee osteoarthritis patients using MRI. Osteoarthr Cartil 2008 ; 16 (Suppl 3): S8-13.
22. Roemer FW, Eckstein F, Guermazi A. Magnetic resonance imaging-based semiquantitative and quantitative assessment in osteoarthritis. Rheum Dis Clin North Am 2009 ; 35 : 521-55.
23. Raynauld JP, Martel-Pelletier J, Abram F, et al. Analysis of the precision and sensitivity to change of different approaches to assess cartilage loss by quantitative MRI in a longitudinal multicentre clinical trial in patients with knee osteoarthritis. Arthritis Res Ther 2008 ; 10 : R129.
24. Bassleer CT, Combal JP, Bougaret S, et al. Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters. Osteoarthr Cartil 1998 ; 6 : 196-204. (Pubitemid 28255110) (Pubitemid 28255110)
25. Ronca F, Palmieri L, Panicucci P, et al. Anti-inflammatory activity of chondroitin sulfate. Osteoarthr Cartil 1998 ; 6 (Suppl A): 14-21. (Pubitemid 28255099) (Pubitemid 28255099)
26. Omata T, Itokazu Y, Inoue N, et al. Effects of chondroitin sulfate-C on articular cartilage destruction in murine collagen-induced arthritis. Arzneimittelforschung 2000 ; 50 : 148-53. (Pubitemid 30114844) (Pubitemid 30114844)
27. Orth MW, Peters TL, Hawkins JN. Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate. Equine Vet J Suppl 2002 : 224-9.
28. Wang L, Wang J, Almqvist KF, et al. Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro. Clin Exp Rheumatol 2002 ; 20 : 669-76. (Pubitemid 35243780) (Pubitemid 35243780)
29. Chan PS, Caron JP, Orth MW. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Am J Vet Res 2005 ; 66 : 1870-6. (Pubitemid 43091705) (Pubitemid 43091705)
30. Chan PS, Caron JP, Orth MW. Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate. J Rheumatol 2006 ; 33 : 1329-40. (Pubitemid 44025148) (Pubitemid 44025148)
31. Tat S K, Pelletier JP, Vergés J, et al. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study. Arthritis Res Ther 2007 ; 9 : R117.
32. Jomphe C, Gabriac M, Hale TM, et al. Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes. Basic Clin Pharmacol Toxicol 2008 ; 102 : 59-65. (Pubitemid 350301907) (Pubitemid 350301907)
33. Monfort J, Pelletier JP, Garcia-Giralt N, et al. Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues. Ann Rheum Dis 2008 ; 67 : 735-40. (Pubitemid 351829371) (Pubitemid 351829371)
34. du Souich P, García AG, Vergés J, et al. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med 2009 ; 13 ( 8A ): 1451-63.
35. Martel-Pelletier J, Kwan Tat S, Pelletier JP. Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review. Osteoarthr Cartil 2010 ; 18 (Suppl 1): S7-11.
36. Leeb BF, Schweitzer H, Montag K, et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2000 ; 27 : 205-11. (Pubitemid 30058651) (Pubitemid 30058651)
37. McAlindon TE, LaValley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000 ; 283 : 1469-75. (Pubitemid 30151826) (Pubitemid 30151826)
38. Richy F, Bruyere O, Ethgen O, et al. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 2003 ; 163 : 1514-22. (Pubitemid 36835094) (Pubitemid 36835094)
39. Hochberg MC, Zhan M, Langenberg P. The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate. Curr Med Res Opin 2008 ; 24 : 3029-35.
40. Lee YH, Woo JH, Choi SJ, et al. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int 2010 ; 30 : 357-63.
41. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986 ; 29 : 1039-49.
42. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957 ; 16 : 494-502.
43. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes. Arthritis Rheum 2004 ; 50 : 476-87. (Pubitemid 38198832) (Pubitemid 38198832)
44. Kauffmann C, Gravel P, Godbout B, et al. Computer-aided method for quantification of cartilage thickness and volume changes using MRI: validation study using a synthetic model. IEEE Trans Biomed Eng 2003 ; 50 : 978-88. (Pubitemid 36917438) (Pubitemid 36917438)
45. Pelletier JP, Raynauld JP, Berthiaume MJ, et al. Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study. Arthritis Res Ther 2007 ; 9 : R74.
46. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes. Arthritis Res Ther 2006 ; 8 : R21.
47. Felson DT, McLaughlin S, Goggins J, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003 ; 139 : 330-6.
48. Hunter DJ, Zhang Y, Niu J, et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 2006 ; 54 : 1529-35.
49. Kijowski R, Stanton P, Fine J, et al. Subchondral bone marrow edema in patients with degeneration of the articular cartilage of the knee joint. Radiology 2006 ; 238 : 943-9. (Pubitemid 43289926) (Pubitemid 43289926)
50. Scher C, Craig J, Nelson F. Bone marrow edema in the knee in osteoarthrosis and association with total knee arthroplasty within a three-year follow-up. Skeletal Radiol 2008 ; 37 : 609-17.
51. Roemer FW, Guermazi A, Javaid MK, et al. Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis. Ann Rheum Dis 2009 ; 68 : 1461-5.
52. Hochberg MC. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthr Cartil 2010 ; 18 (Suppl 1): S28-31.
53. Wandel S, Jüni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010 ; 341 : c4675.
54. Sawitzke AD, Shi H, Finco MF, et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum 2008 ; 58 : 3183-91.
55. Hanna FS, Teichtahl AJ, Wluka AE, et al. Women have increased rates of cartilage loss and progression of cartilage defects at the knee than men: a gender study of adults without clinical knee osteoarthritis. Menopause 2009 ; 16 : 666-70.
56. Raynauld JP, Martel-Pelletier J, Beaulieu A, et al. An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis. Semin Arthritis Rheum 2010 ; 40 : 185-92.
57. Martig S, Boisclair J, Konar M, et al. MRI characteristics and histology of bone marrow lesions in dogs with experimentally induced osteoarthritis. Vet Radiol Ultrasound 2007 ; 48 : 105-12. (Pubitemid 46376363) (Pubitemid 46376363)
58. Albertini R, Passi A, Abuja PM, et al. The effect of glycosaminoglycans and proteoglycans on lipid peroxidation. Int J Mol Med 2000 ; 6 : 129-36.
59. Campo GM, Avenoso A, Campo S, et al. Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res Ther 2003 ; 5 : R122-31.
60. Cho SY, Sim JS, Jeong CS, et al. Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA/1J mice. Biol Pharm Bull 2004 ; 27 : 47-51. (Pubitemid 41656671) (Pubitemid 41656671)
61. Largo R, Roman-Blas JA, Moreno-Rubio J, et al. Chondroitin sulfate improves synovitis in rabbits with chronic antigen-induced arthritis. Osteoarthr Cartil 2010 ; 18 (Suppl 1): S17-23.
62. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006 ; 354 : 795-808. (Pubitemid 43290918) (Pubitemid 43290918)
63. Möller I, Pérez M, Monfort J, et al. Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study. Osteoarthr Cartil 2010 ; 18 Suppl 1 : S32-40.